Gilead Sciences Inc (GILD) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
Gilead Sciences Inc (GILD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.33 Billion. Explore Gilead Sciences Inc (GILD) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$3.33 Billion
USD
Capital Expenditures
$0.00
USD
Gilead Sciences Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Gilead Sciences Inc across 24 annual periods. Also explore GILD asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Gilead Sciences Inc (2002–2025)
Year-by-year capital reinvestment analysis for Gilead Sciences Inc. For live market cap and broader valuation context, see GILD market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $10.02 Billion | $0.00 | ▼ -100.0% |
| 2024 | 0.37x | $3.97 Billion | $10.83 Billion | $523.00 Million | ▲ +17.6% |
| 2023 | 0.31x | $2.50 Billion | $8.01 Billion | $585.00 Million | ▼ -11.4% |
| 2022 | 0.35x | $3.19 Billion | $9.07 Billion | $728.00 Million | ▲ +8.0% |
| 2021 | 0.33x | $3.71 Billion | $11.38 Billion | $579.00 Million | ▼ -78.9% |
| 2020 | 1.54x | $12.60 Billion | $8.17 Billion | $650.00 Million | ▲ +350.3% |
| 2019 | 0.34x | $3.13 Billion | $9.14 Billion | $825.00 Million | ▼ -82.2% |
| 2018 | 1.93x | $16.20 Billion | $8.40 Billion | $924.00 Million | ▲ +306.7% |
| 2017 | 0.47x | $5.64 Billion | $11.90 Billion | $590.00 Million | ▼ -32.5% |
| 2016 | 0.70x | $11.98 Billion | $17.05 Billion | $748.00 Million | ▲ +19.8% |
| 2015 | 0.59x | $12.47 Billion | $21.25 Billion | $747.00 Million | ▲ +312.8% |
| 2014 | 0.14x | $1.82 Billion | $12.82 Billion | $557.00 Million | ▼ -12.6% |
| 2013 | 0.16x | $505.07 Million | $3.10 Billion | $190.00 Million | ▼ -52.5% |
| 2012 | 0.34x | $1.09 Billion | $3.19 Billion | $397.00 Million | ▼ -71.9% |
| 2011 | 1.22x | $4.44 Billion | $3.64 Billion | $131.90 Million | ▲ +87.3% |
| 2010 | 0.65x | $1.85 Billion | $2.83 Billion | $61.88 Million | ▲ +107.3% |
| 2009 | 0.31x | $968.08 Million | $3.08 Billion | $230.06 Million | ▲ +485.8% |
| 2008 | 0.05x | $115.00 Million | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $78.65 Million | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $105.21 Million | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $47.95 Million | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $51.37 Million | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $38.61 Million | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $17.60 Million | $74.41 Million | $17.60 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow